Wim Parys
Keine laufenden Positionen mehr
Profil
Dr. Wim Parys, MD, ist Chief Medical Officer bei argenx SE. Dr. Parys war zuvor als Head-Development bei Tibotec Virco NV und als Gründer bei Tibotec LLC tätig. Er erhielt seinen Hochschulabschluss an der Katholieke Universiteit Leuven.
Ehemalige bekannte Positionen von Wim Parys
| Unternehmen | Position | Ende |
|---|---|---|
| ARGENX SE | Chief Tech/Sci/R&D Officer | 31.03.2022 |
Tibotec Virco NV
 Tibotec Virco NV Miscellaneous Commercial ServicesCommercial Services Tibotec-Virco NV develops drugs and individualized disease management products. The firm also offers early stage research programs concentrating on the development of treatments for cancer, hepatitis C, and other infectious diseases. The company also provides HIV drug resistance testing and other analytical services in the United States, Japan, Europe, Canada, and Australia. It has operations in Belgium, North Carolina, Ireland, and the United Kingdom. It was founded in by Paul Stoffels in March, 2001 and is headquartered in Mechelen, Belgium. | Corporate Officer/Principal | - |
Tibotec LLC
 Tibotec LLC BiotechnologyHealth Technology Part of Johnson & Johnson, Tibotec LLC is a private company that engages in research and development for the treatment of infectious diseases. The company is based in Titusville, NJ. The company was founded by Wim Parys. | Founder | - |
Ausbildung von Wim Parys
| Katholieke Universiteit Leuven | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Tibotec Virco NV
Tibotec Virco NV Miscellaneous Commercial ServicesCommercial Services Tibotec-Virco NV develops drugs and individualized disease management products. The firm also offers early stage research programs concentrating on the development of treatments for cancer, hepatitis C, and other infectious diseases. The company also provides HIV drug resistance testing and other analytical services in the United States, Japan, Europe, Canada, and Australia. It has operations in Belgium, North Carolina, Ireland, and the United Kingdom. It was founded in by Paul Stoffels in March, 2001 and is headquartered in Mechelen, Belgium. | Commercial Services |
Tibotec LLC
Tibotec LLC BiotechnologyHealth Technology Part of Johnson & Johnson, Tibotec LLC is a private company that engages in research and development for the treatment of infectious diseases. The company is based in Titusville, NJ. The company was founded by Wim Parys. | Health Technology |
